Reliq Health Technologies Inc. (OTCQB: RQHTF) (“Reliq” or the “Company“), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has signed an agreement with Hamilton Health Sciences and McMaster University in Hamilton, ON to pilot its remote patient monitoring and care collaboration solution.  The pilot is expected to commence in February 2017.

“We are very excited to work with Hamilton Health Sciences (the “HHS“) and McMaster University to improve health outcomes for patients with Peripheral Arterial Disease (the “PAD“). Our collaboration with McMaster and HHS will allow us to deliver a digital health solution for self-care and patient education that is uniquely tailored to the needs of PAD outpatients.” said Dr. Lisa Crossley, CEO of Reliq Health. “Our platform uses a high tech, low touch approach to provide high quality healthcare in the home, reducing exacerbations and disease-related complications, decreasing healthcare costs and enhancing patient and family satisfaction”.

Peripheral Arterial Disease affects over 800,000 Canadians and over 8 Million Americans. PAD can cause pain, fatigue, poor circulation and slow wound healing in the extremities.  Unless properly managed, PAD can lead to significant complications including infection, gangrene and amputations.  Reliq Health’s proprietary hardware and software supports patients and their caregivers in the home, providing remote monitoring with alerts to clinicians as needed, audible reminders to improve patient compliance with prescribed medication regimens and lifestyle changes, tailored digital patient education materials and secure communication with the entire care team.  Studies have consistently shown that providing patients and families with the tools they need to better understand and manage their clinical conditions at home leads to better health outcomes.


“Dr. Lisa Crossley

CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company“) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

For further information: CORE Capital Partners at 604-566-9233 or

SOURCE Reliq Health Technologies Inc.